Quick Answer
Tyra Biosciences, Inc. reported Shares Outstanding of 53.71 million shares for fiscal year 2025.
Tyra Biosciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 53.71M | +5.8% |
| 2024 | 50.75M | +18.0% |
| 2023 | 43.02M | +1.6% |
| 2022 | 42.35M | +2.2% |
| 2021 | 41.44M | +2165.3% |
| 2020 | 1.83M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 53.32M | +0.8% | +0.2% |
| June 30, 2025 | 53.23M | +0.9% | +0.3% |
| March 31, 2025 | 53.09M | +1.2% | +4.6% |
| December 31, 2024 | 50.75M | +18.0% | -4.0% |
| September 30, 2024 | 52.87M | +23.2% | +0.3% |
| June 30, 2024 | 52.74M | +23.2% | +0.5% |
| March 31, 2024 | 52.47M | +23.4% | +22.0% |
| December 31, 2023 | 43.02M | +1.6% | +0.2% |
- Tyra Biosciences, Inc. showed an increase of +5.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Tyra Biosciences, Inc.’s shares outstanding has grown by 2835.8% (from 1.83 million shares to 53.71 million shares).
- The most recent figure is from Tyra Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: